Lactosylated Gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma

Lactosylated gramicidin-containing lipid nanoparticles (Lac-GLN) were developed for delivery of anti-microRNA-155 (anti-miR-155) to hepatocellular carcinoma (HCC) cells. MiR-155 is an oncomiR frequently elevated in HCC. The Lac-GLN formulation contained N-lactobionyl-dioleoyl phosphatidylethanolamin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Zhang, Mengzi, Zhou, Xiaoju, Wang, Bo, Yung, Bryant C., Lee, Ly J., Ghoshal, Kalpana, Lee, Robert J.
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3672318/
https://ncbi.nlm.nih.gov/pubmed/23567045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2013.03.020
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares